vsmc growth (Dawley Inc)
86
Structured Review
Dawley Inc
vsmc growth
Vsmc Growth, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vsmc+growth/vsmc/pmc13167699-0-68-47
Average 86 stars, based on 1 article reviews
Vsmc Growth, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vsmc+growth/vsmc/pmc13167699-0-68-47
Average 86 stars, based on 1 article reviews
vsmc growth - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
Binding Assay:Article Title: AP ‐1‐Targeting Decoy Oligonucleotides: Mechanisms and Therapeutic Potential as Modulators of Inflammatory Pathways Article Snippet: .. AP‐1 decoy ODN , Vascular remodelling or hypertension‐related vascular disease involving abnormal vascular smooth muscle growth , Ds ODN designed to mimic AP‐1 binding site; often phosphorothioate backbone for stability , Transfection into cultured VSMC , VSMC cultured from rat models such as Wistar‐Kyoto (WKY) rats and Sprague–Dawley rats , AP‐1 decoy ODN blocks Ang II‐stimulated AP‐1 activity, leading to inhibition of TGF‐beta gene expression and reduction in Transfection:Article Title: AP ‐1‐Targeting Decoy Oligonucleotides: Mechanisms and Therapeutic Potential as Modulators of Inflammatory Pathways Article Snippet: .. AP‐1 decoy ODN , Vascular remodelling or hypertension‐related vascular disease involving abnormal vascular smooth muscle growth , Ds ODN designed to mimic AP‐1 binding site; often phosphorothioate backbone for stability , Transfection into cultured VSMC , VSMC cultured from rat models such as Wistar‐Kyoto (WKY) rats and Sprague–Dawley rats , AP‐1 decoy ODN blocks Ang II‐stimulated AP‐1 activity, leading to inhibition of TGF‐beta gene expression and reduction in Cell Culture:Article Title: AP ‐1‐Targeting Decoy Oligonucleotides: Mechanisms and Therapeutic Potential as Modulators of Inflammatory Pathways Article Snippet: .. AP‐1 decoy ODN , Vascular remodelling or hypertension‐related vascular disease involving abnormal vascular smooth muscle growth , Ds ODN designed to mimic AP‐1 binding site; often phosphorothioate backbone for stability , Transfection into cultured VSMC , VSMC cultured from rat models such as Wistar‐Kyoto (WKY) rats and Sprague–Dawley rats , AP‐1 decoy ODN blocks Ang II‐stimulated AP‐1 activity, leading to inhibition of TGF‐beta gene expression and reduction in Activity Assay:Article Title: AP ‐1‐Targeting Decoy Oligonucleotides: Mechanisms and Therapeutic Potential as Modulators of Inflammatory Pathways Article Snippet: .. AP‐1 decoy ODN , Vascular remodelling or hypertension‐related vascular disease involving abnormal vascular smooth muscle growth , Ds ODN designed to mimic AP‐1 binding site; often phosphorothioate backbone for stability , Transfection into cultured VSMC , VSMC cultured from rat models such as Wistar‐Kyoto (WKY) rats and Sprague–Dawley rats , AP‐1 decoy ODN blocks Ang II‐stimulated AP‐1 activity, leading to inhibition of TGF‐beta gene expression and reduction in Inhibition:Article Title: AP ‐1‐Targeting Decoy Oligonucleotides: Mechanisms and Therapeutic Potential as Modulators of Inflammatory Pathways Article Snippet: .. AP‐1 decoy ODN , Vascular remodelling or hypertension‐related vascular disease involving abnormal vascular smooth muscle growth , Ds ODN designed to mimic AP‐1 binding site; often phosphorothioate backbone for stability , Transfection into cultured VSMC , VSMC cultured from rat models such as Wistar‐Kyoto (WKY) rats and Sprague–Dawley rats , AP‐1 decoy ODN blocks Ang II‐stimulated AP‐1 activity, leading to inhibition of TGF‐beta gene expression and reduction in Gene Expression:Article Title: AP ‐1‐Targeting Decoy Oligonucleotides: Mechanisms and Therapeutic Potential as Modulators of Inflammatory Pathways Article Snippet: .. AP‐1 decoy ODN , Vascular remodelling or hypertension‐related vascular disease involving abnormal vascular smooth muscle growth , Ds ODN designed to mimic AP‐1 binding site; often phosphorothioate backbone for stability , Transfection into cultured VSMC , VSMC cultured from rat models such as Wistar‐Kyoto (WKY) rats and Sprague–Dawley rats , AP‐1 decoy ODN blocks Ang II‐stimulated AP‐1 activity, leading to inhibition of TGF‐beta gene expression and reduction in |
